Abstract title: Efficacy and safety of NRTI´s switch to tenofovir plus emtricitabine (Truvada(R)) vs. abacavir plus lamivudine (Kivexa(R)) in patients with virologic suppression receiving a lamivudine containing HAART: the BICOMBO study
Author name: Jose M Gatell

Your full name:

Your e-mail:

Message: (max. 2000 characters)

 (please click only ONCE and wait, as it takes a few seconds)

Please note that your message might be read by IAS staff.